BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Return 108.35%
This Quarter Return
+26.74%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.78B
AUM Growth
+$199M
Cap. Flow
-$23.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
47.19%
Holding
82
New
6
Increased
3
Reduced
8
Closed
9

Top Buys

1
SWTX
SpringWorks Therapeutics
SWTX
$38.4M
2
VTYX icon
Ventyx Biosciences
VTYX
$29.7M
3
VERU icon
Veru
VERU
$28.8M
4
EXEL icon
Exelixis
EXEL
$19.6M
5
GOSS icon
Gossamer Bio
GOSS
$13.3M

Top Sells

1
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$42.9M
2
XBI icon
SPDR S&P Biotech ETF
XBI
$37.1M
3
BPMC
Blueprint Medicines
BPMC
$15.3M
4
BMEA icon
Biomea Fusion
BMEA
$14.2M
5
MIST icon
Milestone Pharmaceuticals
MIST
$14.2M

Sector Composition

1 Healthcare 99.33%
2 Financials 0.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DAWN icon
26
Day One Biopharmaceuticals
DAWN
$773M
$23.8M 1.34%
1,189,943
– –
NUVL icon
27
Nuvalent
NUVL
$5.83B
$23.5M 1.32%
1,210,192
– –
RCKT icon
28
Rocket Pharmaceuticals
RCKT
$354M
$23.4M 1.32%
1,466,051
– –
SRPT icon
29
Sarepta Therapeutics
SRPT
$1.96B
$22.1M 1.24%
200,000
– –
XENE icon
30
Xenon Pharmaceuticals
XENE
$3.02B
$21.7M 1.22%
600,000
– –
ACAD icon
31
Acadia Pharmaceuticals
ACAD
$4.26B
$20.7M 1.16%
1,263,930
– –
EXEL icon
32
Exelixis
EXEL
$10.2B
$19.6M 1.1%
+1,250,000
New +$19.6M
PNT
33
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$19.3M 1.09%
2,500,000
– –
IOVA icon
34
Iovance Biotherapeutics
IOVA
$901M
$18.5M 1.04%
1,935,133
– –
RNA icon
35
Avidity Biosciences
RNA
$6.48B
$18.3M 1.03%
1,121,327
– –
KNTE
36
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$18.2M 1.02%
1,522,559
-325,000
-18% -$3.88M
PRTA icon
37
Prothena Corp
PRTA
$460M
$18.2M 1.02%
300,000
– –
BPMC
38
DELISTED
Blueprint Medicines
BPMC
$18.1M 1.02%
275,000
-232,374
-46% -$15.3M
NRIX icon
39
Nurix Therapeutics
NRIX
$758M
$16M 0.9%
1,224,892
– –
CGEM icon
40
Cullinan Oncology
CGEM
$413M
$13.8M 0.77%
1,074,082
– –
THRD
41
DELISTED
Third Harmonic Bio
THRD
$10.8M 0.61%
+570,417
New +$10.8M
ETNB icon
42
89bio
ETNB
$1.32B
$8.11M 0.46%
1,400,000
– –
FATE icon
43
Fate Therapeutics
FATE
$116M
$7.84M 0.44%
350,000
-150,000
-30% -$3.36M
ASND icon
44
Ascendis Pharma
ASND
$12.5B
$7.23M 0.41%
70,000
– –
TSVT
45
DELISTED
2seventy bio
TSVT
$6.69M 0.38%
459,836
– –
NGM
46
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$6.54M 0.37%
500,000
– –
MIST icon
47
Milestone Pharmaceuticals
MIST
$153M
$6.42M 0.36%
698,861
-1,540,000
-69% -$14.2M
ALT icon
48
Altimmune
ALT
$334M
$6.39M 0.36%
+500,000
New +$6.39M
COGT icon
49
Cogent Biosciences
COGT
$1.82B
$6.34M 0.36%
425,000
– –
RAIN
50
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$5.73M 0.32%
1,175,000
– –
1
2
3 4